Marrow Fibrosis as a Risk Factor for Posttransplantation Outcome in Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with Multilineage Dysplasia-Reference-Cited by-同舟云学术

Marrow Fibrosis as a Risk Factor for Posttransplantation Outcome in Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with Multilineage Dysplasia

Published:2007-03 Issue:3 Volume:13 Page:345-354
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Scott Bart L.,Storer Barry E.,Greene Joanne E.,Hackman Robert C.,Appelbaum Frederick R.,Deeg H. Joachim

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference56 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

2. Proposed revised criteria for the classification of acute myeloid leukemia;Bennett;Ann Intern Med,1985

3. World Health Organization Classification of Tumours;Jaffe,2001

4. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

5. A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes;Malcovati;Blood,2005

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia;Bone Marrow Transplantation;2024-08-27

2. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

3. Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation;Journal of Translational Medicine;2024-03-13

4. Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes;Leukemia & Lymphoma;2023-10-22

5. Significance of bone marrow fibrosis in acute myeloid leukemia for survival in the real-world;Frontiers in Oncology;2022-10-07